Innovent Biologics, Inc. (1801.HK)
HKD 36.2
(-0.82%)
HKD 36.2
(-0.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 147.81 Million | -1.91 Billion | -2.02 Billion | -307.68 Million | -1.66 Billion | -1.01 Billion |
| Net Income | -1.14 Billion | -2.17 Billion | -3.05 Billion | -858.71 Million | -1.71 Billion | -5.87 Billion |
| Depreciation & Amortization | 385.1 Million | 319.42 Million | 204.74 Million | 85.62 Million | 86.36 Million | 64.06 Million |
| Deferred income taxes | - | - | 50.38 Million | 402.29 Million | -14.53 Million | -42.72 Million |
| Stock-based compensation | 574.19 Million | 469.49 Million | 501.57 Million | 402.5 Million | 153.07 Million | 53.43 Million |
| Change in working capital | 403.38 Million | 309.9 Million | -90.28 Million | -334.05 Million | -141.26 Million | 420.59 Million |
| Other non-cash items | -311.41 Million | -847.15 Million | -49.54 Million | -5.34 Million | -28.16 Million | 4.36 Billion |
| Investing Cash Flow | -998.66 Million | -1.43 Billion | -2.69 Billion | -5.18 Billion | -2.56 Billion | 859.41 Million |
| Investments in PPE | -1.38 Billion | -1.38 Billion | -1.84 Billion | -771.77 Million | -365.87 Million | -312.73 Million |
| Acquisitions | - | - | -630.14 Million | 88.71 Million | 70.53 Million | 178.59 Million |
| Investment purchases | -9.41 Billion | -10.32 Billion | -10.33 Billion | -11.64 Billion | -4.85 Billion | -786.47 Million |
| Sales/Maturities of investments | 9.24 Billion | 10.01 Billion | 10.12 Billion | 7.16 Billion | 2.58 Billion | 1.92 Billion |
| Other Investing Activities | 232.35 Million | 252.4 Million | -4.08 Million | -17.21 Million | -5.1 Million | -147.77 Million |
| Financing Cash Flow | 2.58 Billion | 2.89 Billion | 5 Billion | 4.91 Billion | 2.1 Billion | 4.43 Billion |
| Debt repayment | -418.49 Million | -365 Million | -255 Million | -17 Million | -10 Million | -5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | 3.37 Billion |
| Common Stock Issuance | 2.25 Billion | 2.13 Billion | 3.95 Billion | 4.66 Billion | 2.17 Billion | 3.37 Billion |
| Other Financing Activities | 90.89 Million | 1.12 Billion | 1.3 Billion | 266.75 Million | -55.49 Million | 5.04 Billion |
| Accounts receivables | -430.62 Million | 444.92 Million | -493.02 Million | -225.33 Million | -242.53 Million | -8.54 Million |
| Accounts payables | - | - | 493.02 Million | 225.33 Million | 242.53 Million | - |
| Inventory | 358.94 Million | -105.38 Million | -641.58 Million | -311.42 Million | -292.47 Million | -8.39 Million |
| Other working capital | 566.76 Million | -29.62 Million | 551.29 Million | -22.62 Million | 151.21 Million | 437.53 Million |
| Cash at beginning of period | 1.01 Billion | 1.35 Billion | 1.27 Billion | 2.42 Billion | 4.52 Billion | 183.76 Million |
| Cash at end of period | 2.74 Billion | 1.01 Billion | 1.35 Billion | 1.27 Billion | 2.42 Billion | 4.52 Billion |
| Capital Expenditure | -1.38 Billion | -1.38 Billion | -1.84 Billion | -771.77 Million | -365.87 Million | -312.73 Million |
| Effect of forex changes on cash | -6.87 Million | 118.66 Million | -197.14 Million | -569.47 Million | 25.26 Million | 63.83 Million |
| Net cash flow / Change in cash | 1.72 Billion | -343.24 Million | 83.23 Million | -1.14 Billion | -2.09 Billion | 4.34 Billion |
| Free Cash Flow | -1.23 Billion | -3.3 Billion | -3.87 Billion | -1.07 Billion | -2.03 Billion | -1.32 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -196.31 Million | -196.31 Million | -444.38 Million | -1.14 Billion | -444.38 Million | -69.57 Million |
| Depreciation & Amortization | 99.33 Million | 99.33 Million | 91.57 Million | 385.1 Million | 61.29 Million | 93.81 Million |
| Deferred income taxes | - | - | - | - | - | 48.44 Million |
| Stock-based compensation | 148.86 Million | 148.86 Million | 173.6 Million | 574.19 Million | 173.6 Million | 113.49 Million |
| Change in working capital | -59.56 Million | -59.56 Million | 414 Million | 403.38 Million | 414 Million | -166.46 Million |
| Other non-cash items | -100.13 Million | -100.13 Million | 150.54 Million | -311.41 Million | 180.82 Million | -282.71 Million |
| Investing Cash Flow | -276.84 Million | -276.84 Million | -861.85 Million | -998.66 Million | -861.85 Million | 362.52 Million |
| Investments in PPE | -349.75 Million | -349.75 Million | -260.74 Million | -1.38 Billion | -260.74 Million | -298.95 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -9.41 Billion | - | - |
| Sales/Maturities of investments | - | - | - | 9.24 Billion | - | - |
| Other Investing Activities | 72.91 Million | 72.91 Million | -601.1 Million | 232.35 Million | -601.1 Million | 661.47 Million |
| Financing Cash Flow | -130.4 Million | -130.4 Million | 1.17 Billion | 2.58 Billion | 1.17 Billion | 122.34 Million |
| Debt repayment | - | - | - | -418.49 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 2.25 Billion | - | - |
| Other Financing Activities | -130.4 Million | -130.4 Million | 1.17 Billion | 90.89 Million | 1.17 Billion | 122.34 Million |
| Accounts receivables | -181.52 Million | -181.52 Million | 4.8 Million | -430.62 Million | 4.8 Million | -220.11 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 134.56 Million | 134.56 Million | 121.29 Million | 358.94 Million | 121.29 Million | 58.17 Million |
| Other working capital | -12.6 Million | -12.6 Million | 287.9 Million | 566.76 Million | 287.9 Million | -4.52 Million |
| Cash at beginning of period | - | - | - | 1.01 Billion | - | - |
| Cash at end of period | -515.86 Million | -515.86 Million | 706.71 Million | 2.74 Billion | 706.71 Million | 158.05 Million |
| Capital Expenditure | -349.75 Million | -349.75 Million | -260.74 Million | -1.38 Billion | -260.74 Million | -298.95 Million |
| Effect of forex changes on cash | -799.5 Thousand | -799.5 Thousand | 11.92 Million | -6.87 Million | 11.92 Million | -15.36 Million |
| Net cash flow / Change in cash | -515.86 Million | -515.86 Million | 706.71 Million | 1.72 Billion | 706.71 Million | 158.05 Million |
| Free Cash Flow | -457.57 Million | -457.57 Million | 124.6 Million | -1.23 Billion | 124.6 Million | -610.39 Million |
0QW7
CCB
ARTNA
DUFRY
0I4X
2186